Psoriasis is a chronic inflammatory skin disease. Immunological, genetic, and environmental factors, including diet, play a part in the pathogenesis of psoriasis. Metabolic syndrome or its components are frequent co-morbidities in persons with psoriasis. A change of eating habits can improve the quality of life of patients by relieving skin lesions and by reducing the risk of other diseases. A low-energy diet is recommended for patients with excess body weight. Persons suffering from psoriasis should limit the intake of saturated fatty acids and replace them with polyunsaturated fatty acids from the omega-3 family, which have an anti-inflammatory effect. In diet therapy for persons with psoriasis, the introduction of antioxidants such as vitamin A, vitamin C, vitamin E, carotenoids, flavonoids, and selenium is extremely important. Vitamin D supplementation is also recommended. Some authors suggest that alternative diets have a positive effect on the course of psoriasis. These diets include: a gluten-free diet, a vegetarian diet, and a Mediterranean diet. Diet therapy for patients with psoriasis should also be tailored to pharmacological treatment. For instance, folic acid supplementation is introduced in persons taking methotrexate. The purpose of this paper is to discuss in detail the nutritional recommendations for persons with psoriasis.
SummaryStudy aim: the aim of the study was to compare two methods for measuring punching and kicking force and the reaction time of athletes. Material and methods: both systems were designed to measure and to analyse the mechanical characteristics of punches and strikes delivered by upper and lower limbs to a punching bag. The main difference between both punching bags was the way in which the delivered force was measured. The first method used strain gauges while the second method used accelerometer technology. Both systems consisted of a punching bag with software, attached signal diodes, and either embedded accelerometers or strain gauges. The bags were of different sizes. Acceleration transducers and gyroscopes or strain gauges were placed inside the punching bags, which allowed for measuring dynamics while the bag was struck. The software calculated strike force, the point of force application and its direction, and reaction time. Both systems were tested. Results: the results of the accelerometer-based method show that the mean relative error of force calculation amounts to 3%. The measurement error of acceleration is less than 1%. The mean relative measurement error of the striking surface on the punching bag is 2%. However, the measurement error of force recorded with the strain gauge-based method is less than 1%. The results show that both systems are similar. Conclusions: the punching bag having an embedded accelerometer is equipped with more versatile software, which makes the system a good tool for practical application in combat sport training.
SummaryStudy aim: Taekwondo is known for its very dynamic sports fighting, in which the athletes perform strikes mainly with their lower limbs. The aim of the study was to compare the differences between the impact force of strikes performed with the dominant and non-dominant limbs and its correlation with anthropometric indicators.Material and methods: Six elite Olympic taekwondo players took part in the research (20.0 ± 3.2 years, 185.0 ± 8.5 cm, 75.3 ± 10.9 kg). Body composition including body mass, percent of body fat (FATP), fat mass (FATM), fat-free mass (FFM) and muscle mass (MM) was determined by bioelectric impedance analysis. Maximal strike impact force (Fmax) and Fmax relative to FFM (Fmax · FFM−1) of roundhouse kick (dollyo chagi) and side kick (yop chagi) were measured using a dynamometric punching bag with an embedded accelerometer.Results: We found significant differences between the dominant limb (DL) and non-dominant limb (NL) in anthropometric analysis: FATP was 10.52 ± 5.38 % and 11.32 ± 4.83 %, FFM was 11.87 ± 0.97 kg and 11.43 ± 1.09 kg, MM was 11.25 ± 0.92 kg and 10.82 ± 1.02 kg for DL and NL respectively. In dollyo chagi Fmax and Fmax · FFM−1 were higher for DL than NL and were 2733 ± 748 N and 2206 ± 778 N, 41.34 ± 8.16 N · kg−1 and 33.29 ± 9.02 N · kg–1 respectively. Yop chagi has a lower impact force compared to dollyo chagi. Fmax and Fmax · FFM−1 for DL and NL were 1763 ± 303 N and 1779 ± 372 N, 26.76 ± 3.07 N · kg−1 and 26.9 ± 3.57 N · kg–1 respectively. We found a significant correlation between Fmax in yop chagi and FFM (R = 0.83, p < 0.05).Conclusions: Athletes should fight using a stance where the dominant limb is moved further away from the target in order to strike with maximum force.
The aim of the study was to develop a method for measurement and analysis of kinematics of the pelvic girdle movement in breaststroke swimming to support training of technical skills. The measurements were performed in five elite breaststroke swimmers. A recording device for triaxial accelerations and triaxial rotational angular velocity was mounted on the dorsal part of the pelvic girdle of the athlete. The task of the athlete was to swim one length of the 50 m swimming pool with the intensity similar to competition. From the consecutive cycles of swimming motion, we developed individual mean graphical and numerical profiles of the kinematics of the pelvic girdle movement within the average cycle. Mean basic values of the characteristics were compared with the values documented in the literature obtained by means of the video analysis or using the method of measurement of the velocity of the unwound rope. The comparison revealed that the results in the group studied were very similar to the results obtained using other methods and were typical of elite athletes. Analysis of the motion profiles for the pelvic girdle in breaststroke swimmers indicated that the results obtained reflected individual technique of performing individual phases of swimming cycles. The proposed measurement method, presentation and analysis of the profile of the pelvic girdle motion in breaststroke swimming represents a good tool for fast and effective biomechanical evaluation of motion technique components.
The aim of the study was to investigate changes of strength and power of the lower extremities in adolescent handball players during a two-year training cycle. Thirty-one male handball players (age 16.0 ± 0.2 years, body mass 81.4 ± 9.7 kg, body height 188.2 ± 6.4 cm) took part in this study. All tests were conducted three times at the beginning of a one-year training programme. The maximum joint torque (JT) of flexors and extensors of the elbow, shoulder, hip, knee and trunk was measured under static conditions. Power of lower extremities was assessed with a repeated sprint ability (RSA) test on a cycloergometer and jump tests: akimbo counter-movement jump (ACMJ), counter-movement jump (CMJ) and spike jump tests on a force plate. Peak power (PP) increased from 914.8 ± 93.9 to 970.0 ± 89.2 and 1037.8 ± 114.4 W (p < 0.05) following the RSA test results. Maximum power increased significantly (p < 0.05) in ACMJ (1951.9 ± 359.7 to 2141.9 ± 378.5 and 2268.5 ± 395.9 W) and CMJ tests (2646.3 ± 415.6 to 2831.2 ± 510.8 and 3064.6 ± 444.5 W). Although significant differences in JT (p < 0.05) were observed during the two year period, their values related to body mass for the lower right extremity, sum of the trunk and sum of all muscle groups increased significantly between the first and the second measurement (from 13.7 ± 1.8 to 14.58 ± 1.99 N·m·kg-1, from 9.3 ± 1.5 to 10.39 ± 2.16 N·m·kg-1, from 43.4 ± 5.2 to 46.31 ± 6.83 N·m·kg-1, respectively). The main finding of the study is that PP in the RSA test and maximal power in the ACMJ and CMJ increase in relation to training experience and age in the group of youth handball players.
Cancer patients tend to have a high psychological burden. Half of cancer patients suffer from severe affective disorders and anxiety disorders, while one-third struggle with mild forms of these. The COVID-19 pandemic is damaging the mental health of the population due to social restrictions. A growing number of studies note the role of COVID-19 anxiety in the health and quality of life of cancer patients. The purpose of this study is to estimate the level of COVID-19 anxiety among oncology patients and to test the utility of the FCV-19S scale in a population study of cancer patients. The study included 600 respondents (300 oncology patients and 300 control subjects not undergoing oncological treatment). The FCV-19S scale and the GAD-7 scale were used in the study. The results were interpreted according to the following verbal scale: 76–100%, high anxiety; 56–75%, moderate anxiety; 26–55%, low COVID-19 anxiety; <25%, no COVID-19 anxiety. In the analysis of the GAD-7 questionnaire results, the mean score obtained was 8.21 (min. 0; max. 21; SD 5.32). For 81% of respondents in the group of oncology patients, the total score indicated the presence of anxiety symptoms with varying degrees of severity; in the control group, this proportion was 55% of respondents. The FCV-19S scale score as a percentage was 57.4% for oncology patients, indicating a moderate level of fear of the SARS-CoV-2 virus, and 30.3% for the control group, indicating a low level of fear of the SARS-CoV-2 virus. One-fifth of oncology patients were afraid of losing their lives due to the SARS-CoV-2 virus; in the control group, this proportion was 13% of respondents. Oncology patients were characterized by a higher prevalence of sleep disturbance than control group respondents, which was associated with greater anxiety. The study, therefore, shows that oncology patients have moderate levels of anxiety associated with the COVID-19 pandemic, and non-oncology patients show lower levels of anxiety.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.